MD&A Q3_2020 (Eng ) November 2, 2020 Subject : Interim Management Discussion and Analysis of Q3/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the financial

: Management explanation and analysis Quarter 3/2020 ending 30 September 2020 Attention: The President of, The Stock Exchange of Thailand Ziga Innovation Public Company Limited (“the Company”) manufactures and

Page 1 of 3 GEL.CS.001/2563 2 March 2020 Subject: Management Discussion and Financial Analysis for the operating results as at December 31, 2019 To: Director and Manager The Stock Exchange of

Page 1 of 4 No. RJH – SET 7/2020 11 May 2020 Subject : Management’s Discussion and Analysis for the First Quarter of 2020 To : The President The Stock Exchange of Thailand Rajthanee Hospital Public

(Ending March 31, 2020) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial status for the

(Translation) UAC.CS/012/2020 May 14, 2020 Subject: Explanation of the operating results for the first quarter period ended March 31, 2020 To: President The Stock Exchange of Thailand Attachment

Microsoft Word - Operating Result for the first quarter of 2020 SBN 010/2020 May 14, 2020 Subject : Operating Result for the first quarter of 2020 To : The Managing Director, The Stock Exchange of

Discussion and Analysis, Quarter 1 Ending 31 March 2020 (4) The Impact of the COVID-19 situation To: President of the Stock Exchange of Thailand Reference: (1) Document no. Tor. For. 4/2020 dated April 10

Stock Exchange of Thailand The Board of Director’s meeting No. 3/2020 of General Engineering Public Company Limited (“the Company”) held on May 15, 2020 has approved and verified the financial statements

August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries